We offer several performance enhancing peptides to meet the various needs of our patients
Peptide Vials (Tirzepatide, 15 mg each): 8 weeks (2.55 mg/wk): ~30 mg total 2 vials 12 weeks (2.57.5 mg/wk): ~60 mg total 4 vials 16 weeks (2.510 mg/wk): ~100 mg total 7 vials Insulin Syringes (U100, 1 mL): 8 weeks: 8 syringes (1/week) 12 weeks: 12 syringes (1/week) 16 weeks: 20 syringes (1/week wks 112, 2/week wks 1316) Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution
Modo de Uso: Tomar mximo 1 a 3 comprimidos al da, con las comidas
14% less likely to be hospitalized
Safety Considerations for Non-Diabetic Patients Non-diabetic individuals taking GLP-1 medications face similar side effect profiles to diabetic users, with nausea, vomiting, and constipation being most common during dose escalation
Use an alcohol-free fluoride rinse before bed